SAVA HEALTHCARE LIMITED is one of the fastest emerging pharmaceutical organization’s globally under the leadership of Chairman Vinod Ramchandra Jadhav. It has attained noticeable stature in the pharmaceutical arena helping millions of people improve their wellbeing.
SAVA received Tanzania Food and Drug Authority (TFDA) approval for its manufacturing facilities based at Surendranagar, Gujarat – for Tablets, Capsules and Dry powder inhalation capsules, Oral powders, Oral liquid, Ointment/Gel/Cream and Nasal sprays as per the East African Good Manufacturing Practices.
SAVA’s Manufacturing plant has the global accreditation of WHO GMP, HEALTH CANADA, UKRAINE PIC’s, PPB KENYA, MOH KAZAKHSTAN, RUSSIA FDA, NDA UGANDA, and DDA-NEPAL.
DSIR approved in-house R&D Center of SAVA at Pune, India is as a well-equipped Formulations R&D center with highly qualified and skilled scientists engaged in developing quality desired products.
Tanzania is one of the Sub-Saharan African countries attempting to achieve universal health coverage due to the country’s disease burden which is set to increase and hence focusing predominantly into healthcare sectors. It has aimed to reach a market value of USD 605 million with a compound annual growth rate of 6.5% USD terms. Thus, it is a rapidly growing market in the African Region. Tanzania is developing appreciable economic footprints on the grounds of pharmaceutical industries.
Mr. Vinod Ramachandra Jadhav, Chairman of Sava Group, commented, “This certification and Market Entry in Tanzania further strengthens SAVA’s product portfolio capacity and serves the Tanzanian population with its State of the Art therapeutic Finished Formulations. We at SAVA look forward to supplying our Niche products to Private Markets as well as the biggest MSD tenders in Tanzania.”
For more information, visit: http://savaglobal.com/
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly